Additionally, the traditional use of DMARDs and glucocorticoids in RA enhances viral replication via immunosuppression, and the use of biological agents (e.g., TNF-α-inhibitors) also raises the likelihood of viral infection in RA (54–57). The gene discussed is TNF; the disease is rheumatoid arthritis.